National Cancer Action Center

Washington, D.C. - Today, the Trump Administration released the list of 15 drugs for the next round of Medicare price negotiation, including four drugs to treat cancer: Erleada to treat prostate cancer, Kisqali to treat breast cancer, Verzenio to treat breast cancer, and Lenvima to treat thyroid cancer, endometrial cancer,

Today, the Congressional Appropriations Committees released the FY2026 Labor, Health and Human Services, Education and Related Agencies appropriations bill that reaffirms the bipartisan commitment to advancing cancer research and saving lives by continued and increased funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

Following today’s bipartisan House vote on extending the enhanced tax credits, ACS CAN is once again calling on members of the Senate and the House to prioritize the health and wellbeing of their constituents and come together in a bipartisan, bicameral way to extend the enhanced premium tax credits immediately.

With Congress done for the year without extending the enhanced premium tax credits, ACS CAN urges members of the Senate and the House to prioritize the health and wellbeing of their constituents and come together in a bipartisan way to extend these tax credits when they return.